• 1958 Citations
  • 21 Scopus h-Index
19952019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Zelalem Temesgen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
HIV Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Chronic Hepatitis C Medicine & Life Sciences
Opportunistic Infections Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

20 Citations (Scopus)

Building a tuberculosis-free world: The Lancet Commission on tuberculosis

Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., Dybul, M., Farrar, J., Fauci, A. S., Fekadu, E., Fujiwara, P. I., Hallett, T. B., Hanson, C. L., Harrington, M., Herbert, N., Hopewell, P. C. & 57 others, Ikeda, C., Jamison, D. T., Khan, A. J., Koek, I., Krishnan, N., Motsoaledi, A., Pai, M., Raviglione, M. C., Sharman, A., Small, P. M., Swaminathan, S., Temesgen, Z., Vassall, A., Venkatesan, N., van Weezenbeek, K., Yamey, G., Agins, B. D., Alexandru, S., Andrews, J. R., Beyeler, N., Bivol, S., Brigden, G., Cattamanchi, A., Cazabon, D., Crudu, V., Daftary, A., Dewan, P., Doepel, L. K., Eisinger, R. W., Fan, V., Fewer, S., Furin, J., Goldhaber-Fiebert, J. D., Gomez, G. B., Graham, S. M., Gupta, D., Kamene, M., Khaparde, S., Mailu, E. W., Masini, E. O., McHugh, L., Mitchell, E., Moon, S., Osberg, M., Pande, T., Prince, L., Rade, K., Rao, R., Remme, M., Seddon, J. A., Selwyn, C., Shete, P., Sachdeva, K. S., Stallworthy, G., Vesga, J. F., Vilc, V. & Goosby, E. P., Mar 30 2019, In : The Lancet. 393, 10178, p. 1331-1384 54 p.

Research output: Contribution to journalReview article

Tuberculosis

Dolutegravir plus lamivudine dual therapy - A new option for initial antiretroviral therapy

Fida, M., Rizza, S. & Temesgen, Z., May 1 2019, In : Drugs of Today. 55, 5, p. 297-304 8 p.

Research output: Contribution to journalArticle

Lamivudine
Reverse Transcriptase Inhibitors
Integrases
Tenofovir
Drug Combinations
1 Citation (Scopus)

Ibalizumab for the treatment of multidrug-resistant HIV-1 infection

Rizza, S., Bhatia, R., Zeuli, J. & Temesgen, Z., Jan 1 2019, In : Drugs of today (Barcelona, Spain : 1998). 55, 1, p. 25-34 10 p.

Research output: Contribution to journalArticle

HIV Infections
HIV-1
Antiviral Agents
Therapeutics
Antibodies, Monoclonal, Humanized

Polymerase basic protein 2 (PB2) (influenza virus) inhibitor Treatment of influenza A infection

Berg, M. & Temesgen, Z., Jan 1 2019, In : Drugs of the Future. 44, 5, p. 339-348 10 p.

Research output: Contribution to journalArticle

Influenza A virus
P-Glycoprotein
Human Influenza
Adamantane
Cytochrome P-450 CYP3A
1 Citation (Scopus)

Precision medicine and public health interventions: tuberculosis as a model?

Temesgen, Z., Cirillo, D. M. & Raviglione, M. C., Aug 1 2019, In : The Lancet Public Health. 4, 8, p. e374

Research output: Contribution to journalLetter

Open Access
Precision Medicine
Tuberculosis
Public Health